Enfortumab vedotin-ejfv,95.0%
产品编号：Bellancom-P99016A| CAS NO：1346452-25-2
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，
Enfortumab vedotin-ejfv
| 产品介绍 | Enfortumab vedotin-ejfv 是一种 anti-Nectin-4 antibody-drug conjugate，用于尿路上皮癌的研究。 |
|---|---|
| 生物活性 | Enfortumab vedotin-ejfv is an anti-Nectin-4 antibody-drug conjugate for the management of urothelial carcinoma. |
| 体外研究 |
Enfortumab vedotin-ejfv is a fully human IgG1-kappa antibody conjugated to the microtubule-disrupting agent, monomethyl auristatin E (MMAE), via a protease-cleavable maleimidocaproyl valine-citrulline linker (SGD-1006). 西域 has not independently confirmed the accuracy of these methods. They are for reference only. |
| 体内研究 | |
| 体内研究 | |
| 性状 | Solid |
| 溶解性数据 | |
| 运输条件 | |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| 参考文献 |
|
浙公网安备 33010802013016号